Advertisement
General Review|Articles in Press

Superficial Femoral Artery Remote Endarterectomy: A Systematic Review And Meta-analysis

Published:February 28, 2023DOI:https://doi.org/10.1016/j.avsg.2023.02.024

      Abstract

      Background

      Objective: Remote Superficial Femoral Artery Endarterectomy (RSFAE) is a hybrid procedure with low risk for peri-operative complications and promising patency rates over time. The aim of this study was to summarize current literature and to determine the role of RSFAE in limb salvage with regards to technical success, limitations, patency rates and long-term outcomes.

      Methods

      This systematic review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

      Results

      Overall 19 studies were identified, comprising 1,200 patients with extensive femoropopliteal disease among whom 40% presented with chronic limb threatening ischemia. The average technical success rate was 96%, with a 7% rate for peri-operative distal embolization and 13% rate for SFA perforation. The primary patency was 64% and 56%, primary assisted patency was 82% and 77% and secondary patency was 89% and 72% at 12 and 24 months follow up respectively.

      Conclusion

      For long femoropopliteal TASC C/D lesions, RSFAE appears to be a minimally invasive hybrid procedure with acceptable perioperative morbidity, low mortality, and acceptable patency rates. RSFAE should be considered an alternative to open surgery or a bridge to bypass procedure.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • White C.
        Clinical practice. Intermittent claudication.
        The New England journal of medicine. 2007; 356 (2007/03/23): 1241-1250https://doi.org/10.1056/NEJMcp064483
        • Gallagher KA
        • Meltzer AJ
        • Ravin RA
        • et al.
        Endovascular management as first therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy.
        Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2011; 18 (2011/10/14): 624-637https://doi.org/10.1583/11-3539.1
        • Mustapha J
        • Gray W
        • Martinsen BJ
        • et al.
        One-Year Results of the LIBERTY 360 Study: Evaluation of Acute and Midterm Clinical Outcomes of Peripheral Endovascular Device Interventions.
        Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2019; 26 (2019/02/07): 143-154https://doi.org/10.1177/1526602819827295
        • Rudofker EW
        • Hogan SE
        • Armstrong EJ
        Preventing Major Amputations in Patients with Critical Limb Ischemia.
        Curr Cardiol Rep. 2018; 20 (74. 2018/07/12)https://doi.org/10.1007/s11886-018-1019-2
        • Goodney PP
        • Beck AW
        • Nagle J
        • et al.
        National trends in lower extremity bypass surgery, endovascular interventions, and major amputations.
        J Vasc Surg. 2009; 50 (2009/06/02): 54-60https://doi.org/10.1016/j.jvs.2009.01.035
        • Writing Committee M
        • Gerhard-Herman MD
        • Gornik HL
        • et al.
        2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary.
        Vasc Med. 2017; 22 (2017/05/13): NP1-NP43https://doi.org/10.1177/1358863X17701592
        • Katsanos K
        • Kitrou P
        • Spiliopoulos S
        • et al.
        Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
        Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2016; 23 (2016/10/07): 851-863https://doi.org/10.1177/1526602816671740
        • Schillinger M
        • Sabeti S
        • Loewe C
        • et al.
        Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.
        The New England journal of medicine. 2006; 354 (2006/05/05): 1879-1888https://doi.org/10.1056/NEJMoa051303
        • Bunte MC
        • House JA
        • Spertus JA
        • et al.
        Association between health status and long-term mortality after percutaneous revascularization of peripheral artery disease.
        Catheter Cardiovasc Interv. 2016; 87 (2016/02/20): 1149-1155https://doi.org/10.1002/ccd.26442
        • Jones WS
        • Patel MR
        • Tsai TT
        • et al.
        Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization.
        Am Heart J. 2015; 170 (2015/08/25): 400-408https://doi.org/10.1016/j.ahj.2015.04.026
        • Thukkani AK
        • Kinlay S
        Endovascular intervention for peripheral artery disease.
        Circ Res. 2015; 116 (2015/04/25): 1599-1613https://doi.org/10.1161/circresaha.116.303503
        • Schmidt A
        • Bakker OJ
        • Bausback Y
        • et al.
        The tibiopedal retrograde vascular access for challenging popliteal and below-the-knee chronic total occlusions: literature review and description of the technique.
        The Journal of cardiovascular surgery. 2017; 58 (2017/02/17): 371-382https://doi.org/10.23736/s0021-9509.17.09905-0
        • Palena LM
        • Manzi M
        Extreme below-the-knee interventions: retrograde transmetatarsal or transplantar arch access for foot salvage in challenging cases of critical limb ischemia.
        Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2012; 19 (2012/12/06): 805-811https://doi.org/10.1583/jevt-12-3998r.1
        • Montero-Baker M
        • Schmidt A
        • Braunlich S
        • et al.
        Retrograde approach for complex popliteal and tibioperoneal occlusions.
        Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2008; 15 (2008/10/09): 594-604https://doi.org/10.1583/08-2440.1
        • Farber A
        • Rosenfield K
        • Menard M
        The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia.
        Tech Vasc Interv Radiol. 2014; 17 (2014/09/23): 221-224https://doi.org/10.1053/j.tvir.2014.08.012
        • Farber A
        • Menard MT
        • Conte MS
        • et al.
        Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.
        New England Journal of Medicine. 2022; https://doi.org/10.1056/NEJMoa2207899
        • Sangiorgi G
        • Lauria G
        • Airoldi F
        • et al.
        Retrograde popliteal access as bail-out strategy for challenging occlusions of the superficial femoral artery: a multicenter registry.
        Catheter Cardiovasc Interv. 2012; 79 (2012/01/12): 1188-1193https://doi.org/10.1002/ccd.23361
        • Biondi-Zoccai G
        • Sangiorgi G
        • Modena MG
        Devices for infrainguinal endovascular therapy: menu a la carte or table d'hote?.
        Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2011; 18 (2011/10/14): 638-641https://doi.org/10.1583/11-3539c.1
        • Micari A
        • Nerla R
        • Vadala G
        • et al.
        2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
        JACC Cardiovasc Interv. 2017; 10 (2017/04/08): 728-734https://doi.org/10.1016/j.jcin.2017.01.028
        • Bishu K
        • Armstrong EJ
        Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence.
        Vasc Health Risk Manag. 2015; 11 (2015/07/24.): 387-395https://doi.org/10.2147/vhrm.S70229
        • Ali AT
        • Kalapatapu V
        • Ahmed O
        • et al.
        Remote superficial femoral artery endarterectomy: early results for TASC D lesions in patients with severe ischemia.
        Vasc Endovascular Surg. 2007; 41 (2007/08/21): 310-315https://doi.org/10.1177/1538574407302751
        • Gabrielli R
        • Rosati MS
        • Vitale S
        • et al.
        Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions.
        J Vasc Surg. 2012; 56 (2012/10/10): 1598-1605https://doi.org/10.1016/j.jvs.2012.06.081
        • Rosenthal D
        • Martin JD
        • Smeets L
        • et al.
        Remote superficial femoral artery endarterectomy and distal aSpire stenting: results of a multinational study at three-year follow-up.
        The Journal of cardiovascular surgery. 2006; 47 (2006/09/06): 385-391
        • Liberati A
        • Altman DG
        • Tetzlaff J
        • et al.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
        PLoS Med. 2009; 6 (2009/07/22)e1000100https://doi.org/10.1371/journal.pmed.1000100
        • Higgins JP
        • Thompson SG
        • Deeks JJ
        • et al.
        Measuring inconsistency in meta-analyses.
        Bmj. 2003; 327 (2003/09/06): 557-560https://doi.org/10.1136/bmj.327.7414.557
        • Giannopoulos S
        • Lyden SP
        • Bisdas T
        • et al.
        Endovascular Intervention for the Treatment of Trans-Atlantic Inter-Society Consensus (TASC) D Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
        Cardiovasc Revasc Med. 2021; 22 (2020/06/22): 52-65https://doi.org/10.1016/j.carrev.2020.06.014
        • Saaya S
        • Osipova O
        • Gostev A
        • et al.
        A prospective randomized trial on endovascular recanalization with stenting versus remote endarterectomy for the superficial femoral artery total occlusive lesions.
        J Vasc Surg. 2022; 76 (2022/03/02): 158-164https://doi.org/10.1016/j.jvs.2022.02.019
        • Gisbertz SS
        • Tutein Nolthenius RP
        • de Borst GJ
        • et al.
        Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: medium-term results of a randomized controlled trial (the REVAS trial).
        Ann Vasc Surg. 2010; 24 (2010/11/03): 1015-1023https://doi.org/10.1016/j.avsg.2010.03.022
        • Rabtsun A
        • Karpenko A
        • Zoloev DG
        • et al.
        Remote Endarterectomy and Lamina Vastoadductoria Dissection Improves Superficial Femoral Artery Biomechanical Behavior during Limb Flexion.
        Annals of Vascular Surgery. 2018; 50: 112-118https://doi.org/10.1016/j.avsg.2017.12.007
        • Bakoyiannis CN
        • Tsekouras N
        • Matthaiou A
        • et al.
        Guided remote endarterectomy for superficial femoral artery occlusions: a technical note.
        Int Angiol. 2009; 28 (2009/11/26): 380-384
      1. Vijaykumar K TY, Kum S and Tang TY. Remote Endarterectomy for an Occluded Superficial Femoral Artery (SFA) Stent– a Hybrid Technique for the SFA Intervention Toolbox. Surgical Case Reports. DOI: 10.31487/j.SCR.2019.02.016.

        • Tarola CL
        • Young-Speirs M
        • Speirs JWD
        • et al.
        Remote endarterectomy to remove infected Viabahn stent-graft.
        J Vasc Surg Cases Innov Tech. 2021; 7 (2021/07/20): 474-477https://doi.org/10.1016/j.jvscit.2021.04.020
        • Giannopoulos S
        • Armstrong EJ
        Medical therapy for cardiovascular and limb-related risk reduction in critical limb ischemia.
        Vasc Med. 2021; 26 (2021/02/16): 210-224https://doi.org/10.1177/1358863x20987612